Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07392333 · ClinicalTrials.gov registry record
A Prospective Cohort Study of Basivertebral Nerve Ablation Using the Stryker OptaBlate BVN System for the Treatment of Vertebrogenic Low Back Pain
A clinical trial, sponsored by Stryker Instruments.
- Recruiting
- Registry status
- 25
- Enrollment target
NCT07392333 is a clinical trial that is actively recruiting participants, run by Stryker Instruments. The registered enrollment target is 25 participants.
The verdict
NCT07392333 is actively recruiting participants, sponsored by Stryker Instruments.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
Study Summary
The goal of this observational study is to evaluate patient outcomes following treatment of vertebrogenic low back pain using the Stryker OptaBlate BVN System. Patients treated in accordance with the device IFU as part of routine clinical care and who consent to participate will be followed for 12 months after the procedure to assess treatment outcomes.
Interventions
- DEVICE Basivertebral nerve ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-06-02 |
| Est. Completion | 2027-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07392333
The ClinicalTrials.gov registry entry for NCT07392333 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Instruments, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Basivertebral nerve ablation is the first listed.
NCT07392333 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07392333 about?
NCT07392333 is a clinical study titled "A Prospective Cohort Study of Basivertebral Nerve Ablation Using the Stryker OptaBlate BVN System for the Treatment of Vertebrogenic Low Back Pain". The goal of this observational study is to evaluate patient outcomes following treatment of vertebrogenic low back pain using the Stryker OptaBlate BVN System. Patients treated in accordance with the device IFU as part of routine clinical care and who consent to participate will be followed for 12 m...
What is the current status of trial NCT07392333?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2026-06-02. Estimated completion is 2027-11-30.
What interventions are being tested in trial NCT07392333?
The interventions under investigation include: Basivertebral nerve ablation (DEVICE).
Who is sponsoring clinical trial NCT07392333?
This trial is sponsored by Stryker Instruments, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.